What are Non-Treatment Trials and Why are They Important?
When most people think of clinical trials, they think of trials that test new drugs and drug combinations. However, clinical trials also study ways to improve...
Read MoreBlack Wo(Men) Speak Symposium 2022
The Black Wo(Men) Speak Symposium was held before SABCS on December 5, 2022. The goal of the symposium was to highlight the need for increased diversity in...
Read MoreFDA Approves Orserdu and Expands Approval of Trodelvy®
On January 27, 2023, the FDA approved elacestrant (OrserduTM, Stemline Therapeutics, Inc.) and a companion diagnostic test for the treatment of people with...
Read MoreNew ESR1 Biomarker Research Leads to FDA Approval for ER+, HER2- MBC with an ESR1 Mutation
At the end of January 2023, the FDA approved a new drug called elacestrant (OrserduTM) for people with estrogen receptor-positive, HER2-negative MBC with an ESR1...
Read MoreWhat is Stable Disease and How is it Monitored?
Stable disease means your treatments are causing your tumor(s) to either not grow or shrink while no new tumors are developing. If you have stable disease, you...
Read MoreSelf-Advocacy: Your Voice in Your Cancer Care
A cancer diagnosis is scary and overwhelming, and you will meet with many professionals who will offer advice about your care. It is important to remember that...
Read MoreClinical Trial Participation: The Patient’s Journey
Participating in a clinical trial is a process that involves many steps. Click the links below to learn about what to expect while participating in a clinical...
Read MoreMetastatic Trial Search Featured in Clinical Trials Webinar
On January 9th, 2023, our partner, the Dr. Susan Love Foundation for Breast Cancer Research, hosted a clinical trials webinar featuring our very own Susan Colen,...
Read MoreBiomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
A biomarker is a gene, protein, or molecule produced by the body or tumor in a person with cancer that tells a doctor something about the cancer cells. MBC...
Read MoreSEARCH OUR SITE
for past articles or specific information.